Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:2825481rdf:typepubmed:Citationlld:pubmed
pubmed-article:2825481lifeskim:mentionsumls-concept:C0225369lld:lifeskim
pubmed-article:2825481lifeskim:mentionsumls-concept:C0021755lld:lifeskim
pubmed-article:2825481lifeskim:mentionsumls-concept:C0030946lld:lifeskim
pubmed-article:2825481lifeskim:mentionsumls-concept:C1527148lld:lifeskim
pubmed-article:2825481lifeskim:mentionsumls-concept:C0033268lld:lifeskim
pubmed-article:2825481lifeskim:mentionsumls-concept:C0205263lld:lifeskim
pubmed-article:2825481lifeskim:mentionsumls-concept:C0056117lld:lifeskim
pubmed-article:2825481pubmed:issue3-4lld:pubmed
pubmed-article:2825481pubmed:dateCreated1988-1-19lld:pubmed
pubmed-article:2825481pubmed:abstractTextSupernatants from the P388D1 macrophage cell line as well as human interleukin-1 (IL-1) stimulated primary rabbit articular chondrocytes to produce collagen- (C-ase) and proteoglycan- (PG-ase) degrading proteases. The P388D1 derived factor had a molecular weight of 16,000-20,000 and a pI of 4.5-5.0. Both protease activities were metal dependent and inhibited by EDTA, phenanthroline, and alpha 2-macroglobulin but not by PMSF, TLCK, pepstatin, or alpha 1-antitrypsin. Size exclusion chromatography indicated the molecular weights for latent PG-ase and C-ase were 44,000-56,000 and 34,000-44,000, respectively. Chemical synthesis efforts produced two classes of C-ase inhibitors--thiols and hydroxamic acids. The former had IC50 values of 10(-5)-10(-6) M while the latter approached 10(-7) M.lld:pubmed
pubmed-article:2825481pubmed:languageenglld:pubmed
pubmed-article:2825481pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2825481pubmed:citationSubsetIMlld:pubmed
pubmed-article:2825481pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2825481pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2825481pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2825481pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2825481pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2825481pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2825481pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2825481pubmed:statusMEDLINElld:pubmed
pubmed-article:2825481pubmed:monthAuglld:pubmed
pubmed-article:2825481pubmed:issn0065-4299lld:pubmed
pubmed-article:2825481pubmed:authorpubmed-author:PasternakR...lld:pubmed
pubmed-article:2825481pubmed:authorpubmed-author:MarksR LRLlld:pubmed
pubmed-article:2825481pubmed:authorpubmed-author:DiPasqualeGGlld:pubmed
pubmed-article:2825481pubmed:authorpubmed-author:CacceseR GRGlld:pubmed
pubmed-article:2825481pubmed:authorpubmed-author:ConatyJ MJMlld:pubmed
pubmed-article:2825481pubmed:authorpubmed-author:HubbsS JSJlld:pubmed
pubmed-article:2825481pubmed:issnTypePrintlld:pubmed
pubmed-article:2825481pubmed:volume21lld:pubmed
pubmed-article:2825481pubmed:ownerNLMlld:pubmed
pubmed-article:2825481pubmed:authorsCompleteYlld:pubmed
pubmed-article:2825481pubmed:pagination328-30lld:pubmed
pubmed-article:2825481pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:2825481pubmed:meshHeadingpubmed-meshheading:2825481-...lld:pubmed
pubmed-article:2825481pubmed:meshHeadingpubmed-meshheading:2825481-...lld:pubmed
pubmed-article:2825481pubmed:meshHeadingpubmed-meshheading:2825481-...lld:pubmed
pubmed-article:2825481pubmed:meshHeadingpubmed-meshheading:2825481-...lld:pubmed
pubmed-article:2825481pubmed:meshHeadingpubmed-meshheading:2825481-...lld:pubmed
pubmed-article:2825481pubmed:meshHeadingpubmed-meshheading:2825481-...lld:pubmed
pubmed-article:2825481pubmed:meshHeadingpubmed-meshheading:2825481-...lld:pubmed
pubmed-article:2825481pubmed:meshHeadingpubmed-meshheading:2825481-...lld:pubmed
pubmed-article:2825481pubmed:meshHeadingpubmed-meshheading:2825481-...lld:pubmed
pubmed-article:2825481pubmed:meshHeadingpubmed-meshheading:2825481-...lld:pubmed
pubmed-article:2825481pubmed:year1987lld:pubmed
pubmed-article:2825481pubmed:articleTitleInterleukin-1 induces chondrocyte protease production: the development of collagenase inhibitors.lld:pubmed
pubmed-article:2825481pubmed:affiliationStuart Pharmaceuticals, Division of ICI Americans Inc., Wilmington, Delaware.lld:pubmed
pubmed-article:2825481pubmed:publicationTypeJournal Articlelld:pubmed